This paper describes the enantioselective synthesis of analogues of sapinofuranones A and B, namely 5-substitutes dihydro-and 5H-furan-ones, and their in vitro growth inhibitory activity against six cancer cell lines in comparison with fungal furanones such as diplofuranone A, diplobifuranylones A and B, as well as (S,S)-enantiomer of sapinofuranone B. The compounds under study displayed weak if any in vitro growth inhibitory activity against the analysed cancer cell lines. However, it seems that among dihydro-and 5H-furan-ones bearing a 1-hydroxypentyl side chain, the stereochemistry of the furanone ring and that of hydroxylated methine could modify the in vitro growth activity of these compounds. The natural furanones that showed a different unsaturated chain at C-4 or rearranged into a dihydrofuran ring appeared to be inactive in terms of growth inhibitory activity, e.g. displaying growth inhibitory concentration at 50% (GI 50 ) > 100 µM in all six cancer cell lines analysed.
Butanolides are rare as natural products [1] , and among them there are the seiridins, which are the 3,4-dialkylbutenolides isolated from three species of Seiridium responsible for cypress canker [1] . More recently two new 5-substituted dihydrofuranones, named sapinofuranones A and B (1 and 2, Scheme 1), were isolated from Diplodia pinea, a fungus pathogen of conifers (Cupressus macrocarpa Hartw and C. sempervirens L.). They are characterized, as two new phytotoxic 4-[(2Z,4E)-1-hydroxy-2,4-hexadienyl]butan-4-olides epimers at C-1 of the side chain [1] . The absolute configuration of this chiral center, determined by application of the Mosher's method [2] , proved to be S and R in 1 and 2, respectively (Scheme 1). The absolute configuration at C-4 of 2 was determined by comparison of optical rotation values with those of its enantiomer (S,S)-5, the absolute configuration of which was known by total synthesis [1] . Consequently, the absolute configuration (4R,5R) was assigned to 2 and (4R,5S) to 1. Successively, 2 and its (S,S)-enantiomers were also isolated from Diplodia corticola, a fungus involved in cork oak decline. D. corticola is also able to produce sphaeropsidin A, diplopyrone, diplofuranone A (6, Scheme 1) diplobifuranylones A and B (7 and 8, Scheme 1) some of which showed phytotoxic, antifungal and antibacterial activities [1] .
Fürstner et al. [3] demonstrated that some fungal nonenolides (microcarpalide and pinolidoxin) modify the actin cytoskeleton organization. In addition, the same authors reported that certain natural-like furanones displayed similar biological activities [3] . In fact, during the total enantioselective synthesis of microcarpalide, a number of furanones were obtained including 5-(1,5,6-trihydroxydocec-enyl)-dihydrofuran-2-one (3) (Scheme 1), which exhibit an "appreciable potency" in actin microfilament disruption [3] . They also hypothesized that, potentially sapinofuranone A (1) and B (2), cited above, could display similar activity. It must be emphasized that tumor invasiveness and the metastatic potential of cancer cells are tightly associated with the deregulation of the actin cytoskeleton [4] [5] [6] . Therefore, there is the aspiration for the development of future anti-actin compounds to combat metastatic cancers [5, 6] . Moreover, the structurally similar -lactone (-)-muricatacin (4 (Scheme 1), isolated from Annona muricata L., displays cytotoxic activity against a variety of human tumor cell lines [7] . Closely related to 4 is the well known hydroxy decanolide L-factor (12) (Scheme 1), produced by Streptomyces griseus [8] . Thus a new strain of D. corticola was grown again to tentatively isolate sapinofuranone B (2), its (S,S)-enantiomer (5, Scheme 1) and the related furanones, namely diplofuranones A (6), diplobifuranylones A and B (7 and 8) to test their (as well as that of synthetic analogues as below reported) in vitro growth inhibitory activity against five human and one mouse cancer cell lines by means of the MTT colorimetric assay. To investigate the effects on bioactivity of both relative and absolute stereochemistry of these -lactones, as well as that of the double bonds on the side chain, both enantiomers of analogues 9-12 (Scheme 1) were synthesized by asymmetric synthesis and tested in the same MTT-related bioassay in comparison with the natural furanones.
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Although a procedure for the enantioselective synthesis of all four stereoisomers of 5-hydroxy-4-decanolides, i.e. compounds 11-12 and their enantiomers, using the Sharpless asymmetric dihydroxylation as a key step was already reported [9] , a seemingly more straightforward and useful approach to concurrently obtain hydroxy butenolides 9 and 10 was applied. Accordingly, enantioselective 1,2-addition of 2-OTMSfuran to aldehydes was employed [10] . Thus 9 and 10 were synthesized in optically active form by enantioselective addition of 2-(trimethylsilyloxy)furan to hexanal in the presence of a chiral catalyst generated in situ from titanium (IV) isopropoxide and enantiopure BINOL in a 1:2 ratio (Scheme 2) [10] . When (S)-BINOL was used, a 40:60 mixture of diastereoisomers (5S,1′R)-9 and (5R,1′R)-10 was obtained in 88% combined yield. Column chromatography allowed separation of single stereoisomers 9 and 10 in 90% and 100% diastereoisomeric excess (de) while NMR analysis, in the presence of europium complex Eu(hfc) 3 , showed a 76% enantiomeric excess (ee), for both products. By carrying out the reaction with (R)-BINOL, a 40:60 mixture of diastereoisomers (5R,1′S)-ent-9 and (5S,1′S)-ent-10 with the opposite absolute configuration was obtained in 92% combined yield and 92% ee (enantiomeric excess). These four furanones were then separately hydrogenated in methanol over 10% Pd/C at atmospheric pressure of H 2 giving the corresponding decanolides 11, 12, ent-11, and ent-12 in almost quantitative yields. The assigned configuration of the products was confirmed by comparison of the sign of optical rotations with that previously reported for 11 [11] and ent-12 [12] .
The origin of the six cancer cell lines, used in MTT test, is detailed in the Experimental Section. They included two cell lines with relative sensitivity to pro-apoptotic stimuli, i.e. the Hs683 oligodendroglioma and the MCF-7 breast cancer models, and three cancer cell lines with various levels of resistance to pro-apoptotic stimuli, i.e. the A549 non-small-cell lung cancer (NSCLC), the SKMEL-28 melanoma and the U373 glioblastoma models [13] . The mouse cancer cell line relates to the B16F10 melanoma, which displays relative sensitivity to pro-apoptotic stimuli [13] . The data obtained indicated that none of the compounds under study displayed in vitro growth inhibitory activity (GI 50 values > 100 µM) against the A549, Hs683 and SKMEL-28 cancer cell lines (data not shown).
In contrast, the majority of compounds studied, excluding 12 and ent-9, displayed activity against B16F10 melanoma cells with GI 50 growth inhibitory concentrations ranging between 48 and 97 µM ( Table 1) . Three compounds, i.e. 12, 9 and ent-9, displayed growth inhibitory activity in the MCF-7 breast cancer cell line, and two compounds (9 and 10) in the U373 glioblastoma cell line (Table 1) . Thus, only one compound, i.e. 9, displayed in vitro growth inhibitory activity in three (MCF-7, B16F10, U373) cancer cell lines out of the six ones under study. The levels of sensitivity to pro-apoptotic stimuli of the cancer cell lines thus do not seem to impact on the in vitro growth inhibitory activity of 9. Indeed, while Hs683 oligodendroglioma cells are sensitive to pro-apoptotic stimuli [13] , 9 displayed no growth inhibition (GI 50 > 100 µM) in this cancer cell line (data not shown). In the same manner, while U373 cells are rather resistant to pro-apoptotic stimuli [13] , 9 displayed growth inhibitory activity in this model (Table 1) . Thus, 9 could represent a scaffold to obtain novel derivatives significantly more active as anticancer to combat apoptosis-resistant cancer cells.
In conclusion, two furan-2-ones (9 and 10), closely related to the natural sapinofuranones diplofuranone and diplobifuranylones, and their enantiomers (ent-9 and ent-10) were enantioselectively synthesized, as well as the corresponding 3,4-dihydrofuran-2-one (11 and 12) and their enantiomers (ent-11 and ent-12).
The results of their ability to inhibit the in vitro growth of five human and one mouse cancer cell lines, compared to that of the natural furan-2-ones (5) (6) (7) (8) , showed that both the presence of the furan-2-one or its 3,4-dihydro ring is a fundamental feature for the activity. On the contrary, the hydroxylated side chain seems to be less important. The activity of 9 against more cancer cell lines also showed that both the stereochemistry of the ring as well as that of the 1-hydroxyhexyl side chain play an additional role to impart activity. These results agree with those obtained testing the phytotoxic activity of the natural 3,4-furanones 5-8 [1] . The synthetic Furanones with anticancer activity Natural Product Communications Vol. 11 (10) 2016 1473 5-substituted furan-2-one 9 showed potential for further studies focused on developing compounds to combat apoptosis-resistant cancer cells.
Experimental
General: Optical rotations were measured in CHCl 3 on Jasco P-1010 or Jasco DIP-370 digital polarimeters; IR spectra were recorded as glassy film on a Thermo Electron Corporation Nicolet 5700 FT-IR spectrometer and UV spectra were measured in MeCN on a Jasco V-530 spectrophotometer. 1 H and 13 C NMR spectra were recorded at 400/100 or 500/125 MHz in CDCl 3 on Bruker or Varian INOVA spectrometers. The same solvent was used as internal standard. Carbon multiplicities were determined by DEPT spectra. ESI spectra were recorded on an Agilent Technologies 6120 Quadrupole LC/MS instrument. GC-MS analyses were performed using a Hewlett Packard 6890 gas chromatograph, equipped with a mass spectrometric detector HP-5975 type and a capillary column HP-5MS 30 m x 0.25 mm. Analytical and preparative TLC were performed on silica gel (Merck, Kieselgel 60, F 254 , 0.25 and 0.5 mm, respectively) plates. The spots were visualized by exposure to UV radiation (254), or by spraying first with 10% H 2 SO 4 in MeOH and then with 5% phosphomolybdic acid in EtOH. Diethyl ether was freshly distilled prior to its use on sodium benzophenone ketyl under nitrogen atmosphere. Titanium (IV) isopropoxide was distilled at reduced pressure and stored in a nitrogen atmosphere before its use.
Fungal strain: The D. corticola strain used in this study was isolated from stems of infected cork oak (Q. suber) trees collected in March 1996 in Sardinia (Italy). Pure cultures were maintained on potato-dextrose agar (PDA, Fluka, Sigma-Aldrich Chemic GmbH, Buchs, Switzerland) and stored at 4°C in the collection of the Dipartimento di Agraria, University of Sassari, Italy, as PVS 114S. A (1 and 2) : The fungus was grown in 1 L Roux flasks containing 170 mL of Czapek medium amended with 2 % corn meal (pH 5.7). Each flask was seeded with 5 mL of a mycelial suspension and then incubated for 30 days at 25°C. The fungal cultures were vacuum filtered through filter paper (Whatman No. 4) to remove the biomass, and the culture filtrate was collected. The culture filtrate (9.9 L) was acidified to pH 4 with 2 M HCl and extracted exhaustively with EtOAc. The combined organic extracts were dried with Na 2 SO 4 , and evaporated under reduced pressure. The brown-red oil residue (644 mg) of the organic extract was fractioned by CC eluted with CHCl 3 -i-PrOH (97:3). Eight homogeneous fraction groups were collected and screened for their phytotoxic activity. The residue of the third fraction (55 mg) was purified by TLC eluted with n-hexane-EtOAc 5-(1ʹ-hydroxyhexyl)furan-2-(5H)ones 9 and 10  (general procedure) : A solution of (S)-or (R)-BINOL (85 mg, 0.15 mmol) and Ti(Oi-Pr) 4 (0.044 ml, 0.15 mmol) in Et 2 O was stirred at room temperature and under nitrogen atmosphere. After 1 h, hexanal (0.092 ml, 0.75 mmol) was added, the solution was cooled to -20°C and 2-(trimethylsilyloxy)furan (0.188 ml, 1.125 mmol) was added. The reaction was stirred at this temperature for 16 h and monitored by GC-MS analyses. The mixture was quenched with 1.5 mL of a saturated solution of NH 4 Cl and 1.5 mL of 1M HCl solution, warmed to room temperature and stirred for 1 h. After extraction with ethyl acetate (3 x 10 mL), the combined organic phases were dried over Na 2 SO 4 , filtered and concentrated under reduced pressure. Column chromatography (SiO 2 , n-hexane:Et 2 O 1:1) of the obtained orange-brown oil allowed recovery of the BINOL and isolation of a mixture of butenolides 9 and 10 at 88-92% yield and a 40:60 ratio as determined by 1 H NMR spectrum of the crude. Diastereoisomers 9 and 10 (82-100% de) were separated by column chromatography (SiO 2 , n-hexane:EtOAc 1:1) and the ee's were then determined by 1 H NMR analyses in the presence of Eu(hfc) 3 .
Extraction and purification of sapinofuranones

Synthesis of
(5S,1ʹR)-5-(1ʹ-hydroxyhexyl)furan-2-(5H)one 9: obtained with (S)-BINOL in 76% ee and 90% de after chromatographic separation.
[] 25 D : -50 (c 0.5, CHCl 3 ).
(5R,1′S)-5-(1′-hydroxyhexyl)furan-2-(5H)one ent-9: obtained with (R)-BINOL in 90% ee and 100% de after chromatographic separation.
[] 25 D : + 76 (c 0.5, CHCl 3 ). 1 
Synthesis of 5-Hydroxy-4-decanolides 11 and 12 (general procedure):
Decanolides were prepared by hydrogenation of corresponding 2-furanones 9 and 10 following the procedure described below. To a solution of 5-(1′-hydroxyhexyl)furan-2-(5H)one (15 mg, 0.08 mmol) in 1 mL of methanol Pd/C 10 wt. % (20 mg, 0.018 mmol) was added and the mixture was stirred under hydrogen atmosphere at room temperature for 3-6 h. Filtration of the reaction mixture through a pad of Celite, followed by concentration under reduced pressure, yielded the decanolide in 90-100% yields and the same de of the starting 2-furanone.
(4S,5R)-(+)-5-Hydroxy-4-decanolide 11: prepared by hydrogenation of 9.
[] 
Cell Lines:
The human cancer cell lines studied were obtained either from the American Type Culture Collection (ATCC, Manassas, USA), the European Collection of Cell Culture (ECACC, Salisbury, UK) or the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany). The origin and histological type of each cell line analyzed are as follows. Human glioma model lines included the Hs683 oligodendroglioma (ATCC code HTB-138) and the U373 glioblastoma (ECACC code 08061901) cell lines. Melanoma models included the human SKMEL-28 (ATCC code HTB-72) and the mouse B16F10 (ATCC code CRL-6475) cell lines. Human carcinoma models included the A549 NSCLC (DSMZ code ACC 107) and the MCF-7 breast (DSMZ code ACC 115).
The various cancer cell lines were cultured in RPMI culture medium (Lonza code BE12-115F) supplemented with 10% heat-inactivated FBS, 4 mM glutamine (Lonza code BE17-605E), 100 µg/mL gentamicin (Lonza code BE17-518Z), and penicillin-streptomycin (200 units/ml and 200 mg/ml) (Lonza code BE17-602E). The in vitro growth inhibitory activity of the various compounds was determined by means of the MTT colorimetric assay as detailed previously [13] . The in vitro growth inhibitory activity of a compound relates to its GI 50 value, i.e. the concentration that reduces the growth of a given cancer cell line by 50% (as compared to the control condition) after having cultured the cancer cell line for 72 h in the presence of the compound of interested. Based on our own experience, we estimate that a compound does not display in vitro growth inhibitory activity when its GI 50 growth inhibitory concentration is > 100 µM.
